REPRODUCTIVE RIGHTS

Trump spent much of Tuesday’s debate lying about his position on abortion, repeatedly spreading conspiracy theories about Democrats executing infants, and downplaying the very real consequences of the overturning of Roe v. Wade. 

Even as the Biden administration publicly warned hospitals to treat pregnant patients in emergencies, facilities continue to violate the federal law. The issue became a focus for the administration following reports of women being improperly treated in emergency rooms after the Supreme Court’s decision to overturn the constitutional right to an abortion more than two…

For decades, Republicans have spread misinformation — and outright lies — about abortions later in pregnancy, while also spreading conspiracy theories about nonexistent “post-birth” abortions. Here, we separate fact from fiction.

Many policymakers and local issue groups have expressed their support for Kamala Harris as she works to get her name on the ballot for the 2024 election.

Harris has a longstanding history of advocating for reproductive rights, something she’s sure to highlight on the campaign trail as she seeks to paint a stark contrast between herself and former president Donald Trump.

Kennedy said he would support a nationwide 15-week ban, but then changed his mind. He’s also said that he believes the choice of whether or not to have an abortion should stay between women and their doctors while simultaneously touting his plan to “reduce abortion” and “make it easier for women to choose life.”

Project 2025 specifically states that certain types of emergency contraception would be excluded from the no cost coverage provided by the Affordable Care Act should it be implemented.

In the two years since the US Supreme Court overturned Roe v. Wade, Vice President Kamala Harris has become a strong, passionate voice for reproductive rights. 

If they were going to ban abortion, who knew what else they were going to start banning? 

Justice Brett Kavanaugh, writing on behalf of the Supreme Court, wrote that while the plaintiffs did not have standing to sue over the FDA’s regulation of mifepristone, “it is not clear that no one else would have standing to challenge the FDA’s relaxed regulation of mifepristone.”